🎤 Join our founder group to hear from firms like NEA on What it takes to raise a Series A?

Register
Tess Cameron

Tess Cameron

Managing Director·RA Capital Management

Bio

Professional summary

Tess Cameron is a Managing Director on RA Capital's Venture Team, where she works on investments and serves on several company boards. Before RA Capital, she held finance leadership roles at Foghorn Therapeutics, Wave Life Sciences, and Biogen. Earlier, she worked in McKinsey & Company's corporate finance team focused on corporate transactions.

Notable companies

Selected portfolio companies the partner has backed

Avilar Therapeutics

Background

Career, education, and skills

Career history

  • RA Capital ManagementManaging DirectorPresent
  • Foghorn TherapeuticsFinance leadership roles
  • Wave Life SciencesFinance leadership roles
  • BiogenFinance leadership roles
  • McKinsey & CompanyCorporate Finance Specialist

Education

  • University of TorontoBA in Economics and Peace & Conflict Studies

Other partners at RA Capital Management

12 more profiles

Abigail (Lauterbach) Schmitz

Abigail (Lauterbach) Schmitz

Senior Associate

RA Capital Management

TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.

biotech diligencecompetitive landscapesportfolio strategyTechAtlastherapeutics
Adam Prince, MD

Adam Prince, MD

Senior Associate, Strategic Initiatives

RA Capital Management

RA Capital TechAtlas senior associate with cardiology and medical training.

biotech diligencecardiologyhealth innovationportfolio strategyTechAtlas
Alana MacDonald, Ph.D.

Alana MacDonald, Ph.D.

Senior Associate

RA Capital Management

Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.

biotechnologycompetitive landscapesportfolio strategyTechAtlastherapeutics
Alejandro Sevilla

Alejandro Sevilla

Associate

RA Capital Management

Planetary Health associate focused on climate-tech landscapes and investment evaluation.

advanced batteriesclimate technologycompetitive landscapesenergy storageplanetary health
Alex Miller

Alex Miller

Senior Associate, Venture

RA Capital Management

Venture senior associate focused on biotech diligence and portfolio strategy.

biotechnologyprogram strategyTechAtlastherapeuticsventure investing
Alex T. Zhang

Alex T. Zhang

Vice President, Structured Capital

RA Capital Management

Structured Capital VP focused on healthcare and life-sciences credit investments.

commercial-stage healthcarehealthcare creditlife sciencesprivate creditstructured capital
Alexander Martinez-Forte

Alexander Martinez-Forte

Director, Quantitative Research & Strategy

RA Capital Management

RA Capital director leading quantitative analyses for investment decisions and portfolio management.

Data scienceFinancial riskHealthcare investingInvestment analyticsPortfolio managementQuantitative research
Allison Harrigan

Allison Harrigan

Senior Director Corporate Development

RA Capital Management

Raven corporate development leader focused on biotech company creation.

Biotech strategyBusiness developmentCompany creationCorporate developmentDrug discovery
Alyssa Larson

Alyssa Larson

Director, Healthcare Specialist - Investor Relations

RA Capital Management

TechAtlas director supporting healthcare diligence and investor relations.

BiochemistryCompetitive landscapesHealthcare diligenceInvestor relationsTechAtlas
Ami Thakrar, PhD

Ami Thakrar, PhD

Associate

RA Capital Management

TechAtlas associate focused on biotech diligence and program strategy.

biotechnologycompetitive landscapesmedical engineeringprogram strategyTechAtlas
Anish K. More

Anish K. More

Vice President, Corporate Development

RA Capital Management

Raven corporate-development VP focused on investment evaluation and NewCo creation.

company creationcorporate developmenthealthcare servicesNewCosRaven
Anurag Kondapalli

Anurag Kondapalli

Principal

RA Capital Management

Principal investing across public and private healthcare technology and services companies.

healthcare serviceshealthcare technologyprivate investmentspublic investmentsstructured growth capital